Scout, evaluate, and partner with confidence
The Intelligence OS connecting scientific depth and commercial context for smarter asset evaluation
Why DrugBank?
Unified intelligence, deep biological grounding
Comprehensive biomedical and commercial knowledge graph that connects drugs, targets, diseases, sponsors, and trials.
Expert-curated, explainable insights
Gold-standard data backed by decades of scientific validation and 58,000+ academic citations, ensuring transparent provenance.
AI-native interoperability and programmatic access
Our mappings to standard ontologies and flexible access via APIs, MCPs, and agents allow DrugBank to serve as your operational reasoning backbone.
DrugBank enables you to
Identify high-value opportunities
Assess scientific defensibility for emerging therapeutic candidates
Reduce deal risk
Eliminate flawed candidates before they become costly bad bets
Make defensible deal decisions
Accelerate go/no-go outcomes with transparent evidence
Our data
structured data points
evidence-linked publications
investigational & approved drugs
known targets with mechanisms
undrugged targets linked to diseases
Trusted globally by industry leaders in biopharma
Trusted by industry leaders in biopharma
Biopharma Intelligence Operating System
API/MCP
Programmatic access to tools and agents
AI/ML-Ready Datasets
On-premise data access via SQL or Snowflake to your data lake
Explore Data Library“DrugBank enables us to evaluate in-licensing opportunities with far greater speed and clarity. These insights have directly supported our evaluations that progressed to secured opportunities, making them an invaluable decision-support tool.”
One connected view of biology, pharmacology, and clinical development
